Stage IV Mycosis Fungoides/Sezary Syndrome Completed Phase 2 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0028720 (Stage IV Mycosis Fungoides/Sezary Syndrome)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00040846Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological MalignanciesTreatment
NCT00049504Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerTreatment